Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mucous membrane of the pharynx
- Molecular classification
- Other (not a single molecular entity; a tissue made of epithelial cells, connective tissue, mucus, and immune cells)
01
Overview
The mucous membrane of the pharynx is a specialized tissue lining the throat and pharynx, consisting of an epithelial surface supported by connective tissue and containing mucus-secreting glands. This membrane protects against mechanical abrasion, traps pathogens, lubricates the tissue for swallowing and breathing, and plays an important role in local immunity. It comprises multiple cell types, including barrier-forming epithelial cells and resident immune cells[7][5][4]. Although it is essential for health and the target of symptomatic therapies, it is not a molecular target suitable for drug development in itself. Drugs used in the throat and pharynx typically act on the local nerves, immune cells, or infectious organisms rather than on the mucous membrane as a distinct molecular entity.
- Other names
- pharyngeal mucosathroat mucosapharyngeal mucous membrane
02
Mechanism of action
Symptomatic relief via nerve inhibition (anesthetics) Anti-inflammatory effects (NSAID sprays) Antibacterial or antiviral action for infectious agents Not receptor- or enzyme-mediated in the mucous membrane
03
Biological functions
Protection against mechanical and pathogen insultLubricationBarrier to pathogensImmune defense (contains immune cells such as dendritic cells)
04
Disease associations
Infection (e.g., pharyngitis)Inflammation (e.g., sore throat)Cancer (rare: pharyngeal or mucosal tumors)Other (trauma, autoimmune conditions)
05
Safety considerations
Local irritation or tissue damage with prolonged topical drug useAllergic reactions (local or systemic)Masking of progressive disease (e.g., cancer, severe infection)
06
Interacting drugs
Local anesthetics (e.g., benzocaine lozenges for sore throat)
4 more in the full profile.
07
Biomarkers
None specific to the membrane; diagnostic markers (e.g., microbial detection) relate to local disease, not the mucosa itself.
Beyond the preview
Go deeper on Mucous membrane of the pharynx.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mucous membrane of the pharynx.